# EDGAR Filing Document

**Accession Number:** 0002000775
**File Stem:** 0001829126-25-004598
**Filing Date:** 2025-6
**Character Count:** 5079
**Document Hash:** eff33a1552c505dc0967b2dd467eecf0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001829126-25-004598.hdr.sgml**: 20250620

**ACCESSION NUMBER**: 0001829126-25-004598

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250620

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20250620

**DATE AS OF CHANGE**: 20250620

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Black Hawk Acquisition Corp
- **CENTRAL INDEX KEY:** 0002000775
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **FISCAL YEAR END:** 1130

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41984
- **FILM NUMBER:** 251059089

**BUSINESS ADDRESS:**
- **STREET 1:** 4125 BLACKHAWK PLAZA CIRCLE
- **STREET 2:** SUITE 166
- **CITY:** DANVILLE
- **STATE:** CA
- **ZIP:** 94506
- **BUSINESS PHONE:** 203-520-7122

**MAIL ADDRESS:**
- **STREET 1:** 4125 BLACKHAWK PLAZA CIRCLE
- **STREET 2:** SUITE 166
- **CITY:** DANVILLE
- **STATE:** CA
- **ZIP:** 94506

?xml version='1.0' encoding='ASCII'?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION** **Washington, D.C. 20549**

**FORM 8-K**

**Current Report**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

Date of Report (date of earliest event reported): June 20, 2025

**<u>Black Hawk Acquisition Corporation</u>**

(Exact Name of Registrant as Specified in its Charter)

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **6770%** | **N/A** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **4125 Blackhawk Plaza Circle, Suite 166** <br> **Danville, CA** | **94506** |
| (Address of principal executive offices) | (Zip Code) |

---

<u>**(952**</u>**<u>) 217-4482</u>**

(Registrant's telephone number, including area code)

<u>**Not Applicable**</u>

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Units, each consisting of one ordinary share and one-fifth (1/5) of one right | BKHAU | The Nasdaq Stock Market LLC |
| Ordinary shares, par value $0.0001 per share | BKHA | The Nasdaq Stock Market LLC |
| Rights, each right entitling the holder to receive one ordinary share | BKHAR | The Nasdaq Stock Market LLC |

---

**ITEM 8.01. Other Events.** 

On June 20, 2025, Black Hawk Acquisition Corporation (the "Company"), without conducting any business, adjourned its Extraordinary General Meeting of Shareholders (the "Extraordinary General Meeting") in order to solicit additional votes on the matters listed in the notice of extraordinary general meeting and the proxy statement.

The Extraordinary General Meeting has been adjourned to Monday, June 23, 2025 at 2:00 p.m. Eastern Time and will continue to be held virtually.

Only shareholders of record, as of the record date, June 2, 2025 (the "Record Date"), are entitled to vote at the Extraordinary General Meeting, either in person or by proxy. Proxies previously submitted in respect of the Extraordinary General Meeting will be voted at the adjourned Extraordinary General Meeting unless properly revoked, and shareholders who have previously submitted a proxy or otherwise voted need not take any further action.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

June 20, 2025

---

| | |
|:---|:---|
| **Black Hawk Acquisition Corporation** | **Black Hawk Acquisition Corporation** |
| By: | */s/ Kent Louis Kaufman* |
| Name: | Kent Louis Kaufman |
| Title: | Chief Executive Officer |

---